Mason research could change the way concussions are diagnosed

Colleen Rich — Thu, 01 Jul 2021 14:54:19 +0000

Mason research could change the way concussions are diagnosed Colleen Rich Thu, 07/01/2021 - 10:54

Two research professors at 海角社区, in collaboration with global partners, have discovered the same protein biomarkers in the saliva of youth and collegiate athletes who have experienced concussive and sub-concussive impacts.

Shane Caswell

The findings, if validated in larger, independent studies, could be used to develop a new, rapid, noninvasive, saliva-based test for concussion diagnosis and management, as well as a way to monitor changes to the brain following exposure to repetitive sub-concussive impacts.

The study, conducted by Mason professor of athletic training Shane Caswell and University Professor Emanuel Petricoin, was recently published in the Journal of Neurotrauma.

鈥淪alivary biomarker research can, hopefully, enhance already existing tools that diagnose concussions, as well as track brain health over time,鈥� said Caswell, one of the study鈥檚 lead researchers and executive director of Mason鈥檚 Sports Medicine Assessment, Research, and Testing (SMART) Laboratory. 鈥淭his is valuable, not only in all levels of sports, but also in military settings.鈥�

Concussion and repeated sub-concussive impacts, which are blows to the head that do not produce immediate symptoms, could have long-term adverse health consequences if athletes return to contact activity too soon.

Concussion management currently relies on subjective measures to inform clinical judgement. New strides have been made recently, such as a handheld blood test developed by Abbott Laboratories to diagnose concussions. But there continues to be limited understanding of how repeated sub-concussive impacts, that frequently do not cause concussion symptoms, affect the brain.

Emanuel Petricoin

鈥淭here is a need for nonsubjective, diagnostic measures to be able to assess someone鈥檚 traumatic brain injury level, either in a concussed or sub-concussed state,鈥� said Petricoin, co-director of Mason鈥檚 Center for Applied Proteomics and Molecular Medicine (CAPMM). 鈥淭his is important for health care providers so that they can make accurate medical judgements.鈥�

Mason鈥檚 research identified antibodies in saliva that target proteins such as HTR1A, SRRM4, and FAS, which are known to play a role in brain physiology and function. Their presence correlates with concussions and how many hits and athlete sustained during a season of play.

Compared to healthy athletes, individuals who were diagnosed with a concussion, or who suffered high exposure to sub-concussive impacts, showed an elevation of the same salivary biomarkers.

The research team worked with youth, high school, and collegiate athletic teams and their medical staffs across the Washington, D.C., metropolitan area, to collect saliva to create a Sport-Related Head Trauma Salivary Biobank. This first-of-its-kind biobank contains saliva collected from healthy athletes, athletes diagnosed with concussions, and athletes who sustained repetitive sub-concussive impacts.

Sensors worn by the athletes measured the number and severity of hits. Collected saliva was tested using a Mason-developed nanoparticle technology. Analysis was completed by researchers at the KTH Royal Institute of Technology in Stockholm, Sweden, which is a leader in the world of autoimmunity research.

鈥淥nce someone has experienced a concussion, it is hard to know when they are fully healed from it, meaning it may take less of an impact for a second concussion to occur,鈥� Petricoin said. 鈥淚t鈥檚 important to study concussion biomarkers in youth because growing evidence suggests that if we can monitor head impacts more effectively, it will support their long-term health.鈥�

Topics

Research

SMART Lab

Center for Applied Proteomics and Molecular Medicine (CAPMM)

Institute for Biohealth Innovation

College of Education and Human Development